These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21064429)

  • 1. Physiological properties of a new series of sympatholytic agents.
    NICKERSON M; GOODMAN LS
    Fed Proc; 1946; 5(1 Pt 2):194. PubMed ID: 21064429
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of structure to activity in a new series of sympatholytic agents.
    NICKERSON M; NOMAGUCHI G; GOODMAN LS
    Fed Proc; 1946; 5(1 Pt 2):195. PubMed ID: 20983204
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of a series of new sympatholytic agents.
    NICKERSON M; GOODMAN LS
    Rocky Mt Med J; 1947 Apr; 44(4):290. PubMed ID: 20290044
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of a series of new sympatholytic agents (tertiary amines).
    NICKERSON M; GOODMAN LS
    Proc Am Fed Clin Res; 1945; 2():109. PubMed ID: 20275649
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of sympatholytic drugs.
    KING TO
    Fed Proc; 1947; 6(1):345. PubMed ID: 20249590
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of sympatholytic effects of priscol, etamon, and dibenamine in dogs with results of actual sympathectomy.
    MARZONI FA; REARDON MJ
    Surgery; 1949 Jul; 26(1):117-30. PubMed ID: 18131979
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenolytic and sympatholytic actions of priscol (benzyl-imidazoline).
    CHESS D; YONKMAN FF
    Proc Soc Exp Biol Med; 1946 Feb; 61():127-30. PubMed ID: 21017595
    [No Abstract]   [Full Text] [Related]  

  • 8. A sympatholytic (adrenergic blocking) substance (dibenzyl-beta-chloroethyl ethyl ammonium bromide) with rapid action and high activity in animal experiments.
    NYMAN E
    Nature; 1949 Aug; 164(4163):269 !V17(49) R-00933. PubMed ID: 18240402
    [No Abstract]   [Full Text] [Related]  

  • 9. The sympathetic nervous system as a target for the treatment of hypertension and cardiometabolic diseases.
    Sorota S
    J Cardiovasc Pharmacol; 2014 May; 63(5):466-76. PubMed ID: 24805148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on the autonomic nervous system. IV. Action of sympatholytic substances injected during hypertension induced by perfusion with sympathomimetic amines or by the activity of sympathetic nerves].
    SCHMITT H
    Arch Int Pharmacodyn Ther; 1958 Apr; 114(3-4):397-417. PubMed ID: 13534831
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of moxonidine on sympathetic nerve activity in patients with end-stage renal disease.
    Hausberg M; Tokmak F; Pavenstädt H; Krämer BK; Rump LC
    J Hypertens; 2010 Sep; 28(9):1920-7. PubMed ID: 20634720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympatholytic effects of quinine and quinidine.
    Hiatt EP
    Am J Physiol; 1950 Jan; 160(1):212-6. PubMed ID: 15409761
    [No Abstract]   [Full Text] [Related]  

  • 13. [On Some Physiological Properties and In Particular On the Sympatholytic Action Of Corynantheidine].
    PARIS R; JANOT MM; GOUTAREL R
    C R Seances Soc Biol Fil; 1945 Jul; 139():665. PubMed ID: 21023451
    [No Abstract]   [Full Text] [Related]  

  • 14. Is "cardiovascular protection" by estrogens due to inhibition of the sympathetic nervous system?
    Esler M; Dawood T
    Clin Auton Res; 2005 Jun; 15(3):186-8. PubMed ID: 15944866
    [No Abstract]   [Full Text] [Related]  

  • 15. [EFFECTS OF SOME SYMPATHOLYTIC DRUGS ON PUPILLARY RESPONSE TO ELECTRIC STIMULATION OF THE CERVICAL SYMPATHIC OF THE RABBIT].
    BONOMI L
    Boll Ocul; 1964 Jan; 43():55-68. PubMed ID: 14218206
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological examination of pendiomid, a new substance with ganglia-blocking effect].
    BEIN HJ; MEIER R
    Schweiz Med Wochenschr; 1951 May; 81(19):446-52. PubMed ID: 14866005
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the role of the sympathetic nervous system in the pathogenesis of the Raynaud phenomenon secondary to the use of vibrating instruments. I. Effect of sympatholytic drugs].
    Casula D; Nissardi GP; Gessa GL; Sanna-Randaccio F
    Boll Soc Ital Biol Sper; 1968 Feb; 44(3):138-41. PubMed ID: 5687945
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin.
    McCall RB; Schuette MR
    J Pharmacol Exp Ther; 1984 Mar; 228(3):704-10. PubMed ID: 6323678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicalexperimental and therapeutic observations with pendiomid, a new gangliablocking substance].
    BERNSMEIER A; ESSER H; LORENZ W
    Schweiz Med Wochenschr; 1951 May; 81(19):452-6. PubMed ID: 14866006
    [No Abstract]   [Full Text] [Related]  

  • 20. [INFLUENCE OF THE INHIBITION OF THE SYMPATHETIC NERVOUS SYSTEM ON THE NONESTERIFIED FATTY ACID (NEFA) LEVEL OF THE BLOOD.I. THE CHANGES INDUCED BY A SUBSTANCE WITH SYMPATHOLYTIC ACTION].
    GUARNIERI E; GIARDINA A
    Rass Neurol Veg; 1963 Aug; 17():278-86. PubMed ID: 14090097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.